First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report

First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report

Abstract Background The acquired resistance to ALK tyrosine kinase inhibitors (TKIs) in ALK-rearranged NSCLC is associated with poor survival outcomes and poses distinct clinical challenges. It is essential to develop potential therapeutic strategies for overcoming resistance. Case presentation Here...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Shuang Yang, Weineng Feng, Yanming Deng, Jianmiao Liang
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: BMC 2023-03-01
Cyfres:World Journal of Surgical Oncology
Pynciau:
Ensartinib
ALK rearranged
ALK I1171N
Lung caner
Mynediad Ar-lein:https://doi.org/10.1186/s12957-023-02935-9

Rhyngrwyd

https://doi.org/10.1186/s12957-023-02935-9

Eitemau Tebyg